Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castleman's disease (MCD). KS is still the most common AIDS-defining cancer in HIV-positive individuals, although KS can also occur in HIV-negative individuals. In certain regions of sub-Saharan Africa, KS is the most prevalent cancer. Other immunosuppressed individuals such as transplant patients also develop KS much more frequently than the healthy population. We have previously reported that activation of the PI3K/Akt/mTOR signaling pathway is critical for survival of KSHV-infected cells as well as the survival of KS and PEL tumors. We have reported that KSHV and the K1 and ORF36/vPK viral proteins are important for activating different nodes of the PI3K/Akt/mTOR pathway. Our overarching hypothesis is that KSHV viral proteins, including ORF36/vPK, modulate cellular signaling pathways that are also conducive to transformation. In this application, we propose to determine the mechanisms by which ORF36/vPK can modulate cell proliferation, signaling, and angiogenesis pathways. We will also explore novel host factors that are critical for survival and proliferation of KSHV infected cells. The proposed studies will provide significant, and biologically relevant insights into the functions of viral signaling proteins, and may yield a new target for anti-KSHV therapies.

Public Health Relevance

We propose to identify how KSHV viral proteins modulate cell proliferation and angiogenesis. The proposed studies will provide significant, and biologically relevant insights into the functions of viral signaling proteins, and may yield a new target for anti-KSHV therapies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA096500-16
Application #
9623396
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
2002-07-15
Project End
2023-07-31
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
16
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Anders, Penny M; Montgomery, Nathan D; Montgomery, Stephanie A et al. (2018) Human herpesvirus-encoded kinase induces B cell lymphomas in vivo. J Clin Invest 128:2519-2534
Wong, Jason P; Damania, Blossom (2017) Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus. Biol Chem 398:911-918
Zhang, Zhigang; Chen, Wuguo; Sanders, Marcia K et al. (2016) The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication. J Virol 90:7657-66
Ma, Zhe; Damania, Blossom (2016) Editorial: NLRP3: immune activator or modulator? J Leukoc Biol 99:641-3
Bhatt, Aadra Prashant; Wong, Jason P; Weinberg, Marc S et al. (2016) A viral kinase mimics S6 kinase to enhance cell proliferation. Proc Natl Acad Sci U S A 113:7876-81
Damania, Blossom (2016) A Virological Perspective on Cancer. PLoS Pathog 12:e1005326
Ma, Zhe; Damania, Blossom (2016) The cGAS-STING Defense Pathway and Its Counteraction by Viruses. Cell Host Microbe 19:150-8
Dittmer, Dirk P; Damania, Blossom (2016) Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy. J Clin Invest 126:3165-75
Anders, Penny M; Zhang, Zhigang; Bhende, Prasana M et al. (2016) The KSHV K1 Protein Modulates AMPK Function to Enhance Cell Survival. PLoS Pathog 12:e1005985
Johnson, Amy R; Qin, Yuanyuan; Cozzo, Alyssa J et al. (2016) Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation. Mol Metab 5:506-526

Showing the most recent 10 out of 64 publications